The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study
Open accessAbstract
BACKGROUND: Plasmodium vivax exacts a significant toll on health worldwide, yet few efforts to date have quantified the extent and temporal trends of its global distribution. Given the challenges associated with the proper diagnosis and treatment of P vivax, national malaria programmes-particularly those pursuing malaria elimination strategies-require up to date assessments of P vivax endemicity and disease impact. This study presents the first global maps of P vivax clinical burden from 2000 to 2017. METHODS: In this spatial and temporal modelling study, we adjusted routine malariometric surveillance data for known biases and used socioeconomic indicators to generate time series of the clinical burden of P vivax. These data informed Bayesian geospatial models, which produced fine-scale predictions of P vivax clinical incidence and infection prevalence over time. Within sub-Saharan Africa, where routine surveillance for P vivax is not standard practice, we combined predicted surfaces of Plasmodium falciparum with country-specific ratios of P vivax to P falciparum. These results were combined with surveillance-based outputs outside of Africa to generate global maps. FINDINGS: We present the first high-resolution maps of P vivax burden. These results are combined with those for P falciparum (published separately) to form the malaria estimates for the Global Burden of Disease 2017 study. The burden of P vivax malaria decreased by 41·6%, from 24·5 million cases (95% uncertainty interval 22·5-27·0) in 2000 to 14·3 million cases (13·7-15·0) in 2017. The Americas had a reduction of 56·8% (47·6-67·0) in total cases since 2000, while South-East Asia recorded declines of 50·5% (50·3-50·6) and the Western Pacific regions recorded declines of 51·3% (48·0-55·4). Europe achieved zero P vivax cases during the study period. Nonetheless, rates of decline have stalled in the past five years for many countries, with particular increases noted in regions affected by political and economic instability. INTERPRETATION: Our study highlights important spatial and temporal patterns in the clinical burden and prevalence of P vivax. Amid substantial progress worldwide, plateauing gains and areas of increased burden signal the potential for challenges that are greater than expected on the road to malaria elimination. These results support global monitoring systems and can inform the optimisation of diagnosis and treatment where P vivax has most impact. FUNDING: Bill & Melinda Gates Foundation and the Wellcome Trust.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most P. vivax cases are in geographic areas of the WHO Regional Offices for South-East Asia and Eastern Mediterranean [19]”
From Global estimates of pregnancies at risk of Plasmodium falciparum and Plasmodium vivax infection in 2020 and changes in risk patterns since 2000 (2022) · cites this paper as [19]
In the citing paper
“Since 2007 there have been decreases in the prevalence of P. falciparum [12] and P. vivax [19], as well as global fertility rates [21, 22], although absolute populations have grown at regional and global levels.”
From Global estimates of pregnancies at risk of Plasmodium falciparum and Plasmodium vivax infection in 2020 and changes in risk patterns since 2000 (2022) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationThe effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, U., Battle, K. E., Moyes, C. L., Henry, A., Eckhoff, P. A., et al. (2015) · Nature · doi:10.1038/nature15535 · Cited by 3,225
Self-citationThe Resistance Factor toPlasmodium vivaxin Blacks
Miller, L. H., Mason, S. J., CLYDE, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,259
The global distribution and population at risk of malaria: past, present, and future
Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M., & Snow, R. W. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01043-6 · Cited by 1,002
The neglected burden of Plasmodium vivax malaria
Mendis, K., Sina, B. J., Marchesini, P. B., & Carter, R. (2001) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.97 · Cited by 976
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 840
Asymptomatic malaria infections: detectability, transmissibility and public health relevance
Bousema, T., Okell, L., Felger, I., & DRAKELEY, C. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3364 · Cited by 685
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Müeller, I., Galinski, M. R., Baird, J. K., Carlton, J. M., Kochar, D. K., Alonso, P. L., & Portillo, H. A. D. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70177-x · Cited by 661
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
Gething, P. W., Elyazar, I., Moyes, C. L., Smith, D. L., Battle, K. E., Guerra, C. A., Patil, A. P., Tatem, A. J., Howes, R. E., Myers, M. F., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001814 · Cited by 560
Self-citation
Cited by
Sorted by citations
Items 101–200 of 408
Malaria vaccines: facing unknowns
Palacpac, N., & Horii, T. (2020) · F1000Research · doi:10.12688/f1000research.22143.1 · Cited by 17
Whittaker, C., Winskill, P., Sinka, M. E., Pironon, S., Massey, C., Weiss, D. J., Nguyen, H. L. T., Gething, P. W., Kumar, A., Ghani, A. C., et al. (2022) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2022.0089 · Cited by 17
Structural basis for DARC binding in reticulocyte invasion by Plasmodium vivax
Moskovitz, R., Pholcharee, T., DonVito, S. M., Guloglu, B., Lowe, E. D., Mohring, F., Moon, R. W., & Higgins, M. K. (2023) · Nature Communications · doi:10.1038/s41467-023-39357-w · Cited by 20
Santos, M. L. S., Coimbra, R. S., de Sousa, T. N., Guimarães, L. F. F., Gomes, M. D. S., do Amaral, L. R., Pereira, D. B., Fontes, C. J. F., Hawwari, I., Franklin, B. S., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.631333 · Cited by 16
Plasmodium vivax pre-erythrocytic vaccines
Reyes‐Sandoval, A. (2021) · Parasitology International · doi:10.1016/j.parint.2021.102411 · Cited by 17
Kundu, P., Naskar, D., McKie, S. J., Dass, S., Kanjee, U., Introini, V., Ferreira, M. U., Cicuta, P., Duraisingh, M., Deane, J. E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40885-8 · Cited by 14
Danwang, C., Noubiap, J. J., Souopgui, J., Gaudart, J., Yombi, J. C., & Robert, A. R. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-005634 · Cited by 17
Parasitological profiling shows 4(1H)-quinolone derivatives as new lead candidates for malaria
de Souza, J. O., Almeida, S. M., Souza, G. E., Zanini, C. L., da Silva, E. M., Calit, J., Bargieri, D. Y., Amporndanai, K., Antonyuk, S. V., Hasnain, S. S., et al. (2021) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2021.100012 · Cited by 16
Evolutionary history of Plasmodium vivax and Plasmodium simium in the Americas
Rougeron, V., Daron, J., Fontaine, M. C., & Prugnolle, F. (2022) · Malaria Journal · doi:10.1186/s12936-022-04132-7 · Cited by 45
Hypnozoite depletion in successive Plasmodium vivax relapses
Noviyanti, R., Carey-Ewend, K., Trianty, L., Parobek, C. M., Puspitasari, A. M., Balasubramanian, S., Park, Z., Hathaway, N. J., Utami, R. A. S., Soebianto, S., et al. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010648 · Cited by 16
Dzianach, P. A., Rumisha, S. F., Lubinda, J., Saddler, A., van den Berg, M., Gelaw, Y. A., Harris, J. R., Browne, A. J., Sanna, F., Rozier, J. A., et al. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8040216 · Cited by 16
Danwang, C., Khalil, É., Achu, D., Ateba, M., Abomabo, M. H. R., Souopgui, J., Keukeleire, M. D., & Robert, A. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90997-8 · Cited by 16
Han, J. H., Cho, J.-S., Ong, J. J. Y., Park, J.-H., Nyunt, M. H., Sutanto, E., Trimarsanto, H., Petros, B., Aseffa, A., Getachew, S., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008202 · Cited by 16
Baird, J. K. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.696598 · Cited by 15
Naz, S., Ahmad, S., Abbasi, S. W., Ismail, S., Waseem, S., Qamar, M. T. U., Almatroudi, A., & Ali, Z. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105120 · Cited by 15
Quagliata, M., Papini, A. M., & Rovero, P. (2023) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2023.2190884 · Cited by 15
A systematic analysis of the human immune response to Plasmodium vivax
Bach, F. A., Sandoval, D. M., Mazurczyk, M., Themistocleous, Y., Rawlinson, T. A., Harding, A. C., Kemp, A. C., Silk, S. E., Barrett, J. R., Edwards, N. J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci152463 · Cited by 16
GIS-based spatiotemporal mapping of malaria prevalence and exploration of environmental inequalities
Ogunsakin, R. E., Babalola, B. T., Olusola, J. A., AYODELE, O. J., & Okpeku, M. (2024) · Parasitology Research · doi:10.1007/s00436-024-08276-0 · Cited by 15
Devine, A., Howes, R. E., Price, D. J., Moore, K. A., Ley, B., Simpson, J. A., Dittrich, S., & Price, R. N. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0943 · Cited by 13
Huber, J. H., Koepfli, C., España, G., Nekkab, N., White, M. T., & Perkins, T. A. (2021) · Malaria Journal · doi:10.1186/s12936-021-04017-1 · Cited by 16
Li, G., Zhang, D. “., Chen, Z., Feng, D., Cai, X., Chen, X., Tang, S., & Feng, Z. (2022) · Malaria Journal · doi:10.1186/s12936-021-04006-4 · Cited by 16
Degaga, T. S., Pasaribu, A. P., Tripura, R., Ghanchi, N. K., Rajasekhar, M., Adhikari, B., Ley, B., Bamboro, S. A., Jabbar, F. A., Hasibuan, N., et al. (2026) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00729-7 · Cited by 14
Improving disaggregation models of malaria incidence by ensembling non-linear models of prevalence
Lucas, T. C. D., Nandi, A., Keddie, S., Chestnutt, E. G., Howes, R. E., Rumisha, S. F., Arambepola, R., Bertozzi-Villa, A., Python, A., Symons, T. L., et al. (2020) · Spatial and Spatio-temporal Epidemiology · doi:10.1016/j.sste.2020.100357 · Cited by 14
Self-citationGrimée, M., Tacoli, C., Sandfort, M., Obadia, T., Taylor, A. R., Vantaux, A., Robinson, L. J., Lek, D., Longley, R. J., Müeller, I., et al. (2024) · Malaria Journal · doi:10.1186/s12936-024-04859-5 · Cited by 14
Chali, W., Ashine, T., Hailemeskel, E., Gashaw, A., Tafesse, T., Lanke, K. H. W., Esayas, E., Kedir, S., Shumie, G., Behaksra, S. W., et al. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-3998-2 · Cited by 14
Pasini, E. M., & Kocken, C. H. M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.614122 · Cited by 14
Stewart, A., Zimmerman, P. A., & McCarthy, J. S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.784909 · Cited by 14
Ruwanpura, V., Neukom, J., Grietens, K. P., Price, R. N., Thriemer, K., & Lynch, C. A. (2021) · Malaria Journal · doi:10.1186/s12936-021-03959-w · Cited by 14
Individual variation in Plasmodium vivax malaria risk: Are repeatedly infected people just unlucky?
Corder, R. M., Arez, A. P., & Ferreira, M. U. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011020 · Cited by 12
Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration
Anwar, M. N., Hickson, R. I., Mehra, S., Price, D. J., McCaw, J. M., Flegg, M. B., & Flegg, J. A. (2023) · Bulletin of Mathematical Biology · doi:10.1007/s11538-023-01153-4 · Cited by 13
Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein
Dickey, T. H., & Tolia, N. H. (2023) · Trends in Parasitology · doi:10.1016/j.pt.2023.06.011 · Cited by 13
Bulafu, D., Tamale, B. N., Ninsiima, L. R., Baguma, J. N., Namakula, L. N., Niyongabo, F., Lubega, G. B., Aruhomukama, D., Ndejjo, R., & Musoke, D. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002220 · Cited by 13
Verma, R., Commons, R. J., Gupta, A., Rahi, M., Nitika, Bharti, P. K., Thriemer, K., Rajasekhar, M., Singh-Phulgenda, S., Adhikari, B., et al. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012675 · Cited by 13
Pian, H., Wang, H., Wang, H., & Li, Z. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00230 · Cited by 13
A retrospective analysis of the malaria trend in Yemen over the sixteen-years, from 2006 to 2021
Edrees, W. H., & Al-Shehari, W. A. (2025) · BMC Public Health · doi:10.1186/s12889-025-21466-4 · Cited by 13
Meeting report: WHO consultation on malaria vaccine development, Geneva, 15–16 July 2019
Vekemans, J., Schellenberg, D. M., Benns, S., O’Brien, K. L., & Alonso, P. L. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.03.093 · Cited by 13
Favas, C., Jarrett, P., Ratnayake, R., Watson, O. J., & Checchi, F. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.11.004 · Cited by 12
A Multiscale Mathematical Model of Plasmodium Vivax Transmission
Anwar, M. N., Hickson, R. I., Mehra, S., McCaw, J. M., & Flegg, J. A. (2022) · Bulletin of Mathematical Biology · doi:10.1007/s11538-022-01036-0 · Cited by 13
Bhattarai, S., Blackburn, J. K., & Ryan, S. J. (2022) · Malaria Journal · doi:10.1186/s12936-022-04417-x · Cited by 14
Bâ, H., Auburn, S., Jacob, C. G., Gonçalves, S., Duffy, C. W., Stewart, L. B., Price, R. N., Deh, Y. B., Diallo, M. Y., Tandia, A., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008945 · Cited by 11
Riaz, M., Sial, M. H., Sharif, S., & Mehmood, Q. (2023) · Journal of Environmental and Public Health · doi:10.1155/2023/8907610 · Cited by 12
Schmit, N., Topazian, H. M., Pianella, M., Charles, G. D., Winskill, P., White, M. T., Hauck, K., & Ghani, A. C. (2023) · eLife · doi:10.7554/elife.88283 · Cited by 13
Pottenger, A. E., Roy, D., Srinivasan, S., Chavas, T. E. J., Vlaskin, V. A., Ho, D., Livingston, V. C., Maktabi, M., Lin, H., Zhang, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk4492 · Cited by 11
Cassidy-Seyoum, S. A., Chheng, K., Chanpheakdey, P., Meershoek, A., Hsiang, M. S., von Seidlein, L., Tripura, R., Adhikari, B., Ley, B., Price, R. N., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003476 · Cited by 12
Eng, V., Lek, D., Sin, S., Feufack-Donfack, L. B., Orbán, Á., Salvador, J., Seng, D., Heng, S., Khim, N., Tebben, K., et al. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00033-7 · Cited by 12
The changing risk patterns ofPlasmodium vivaxmalaria in Greece due to climate change
Trájer, A. J. (2020) · International Journal of Environmental Health Research · doi:10.1080/09603123.2020.1793918 · Cited by 12
Mapping Malaria by Sharing Spatial Information Between Incidence and Prevalence Data Sets
Lucas, T. C. D., Nandi, A. K., Chestnutt, E. G., Twohig, K. A., Keddie, S., Collins, E. L., Howes, R. E., Nguyen, H. L. T., Rumisha, S. F., Python, A., et al. (2021) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/rssc.12484 · Cited by 14
Self-citationMukaka, M., Peerawaranun, P., Parker, D. M., Kajeechiwa, L., Nosten, F. H., Nguyen, T.-N., Hien, T. T., Tripura, R., Peto, T. J., Phommasone, K., et al. (2021) · Malaria Journal · doi:10.1186/s12936-021-03879-9 · Cited by 10
Bhavnani, D., Espinosa, B. G., Baird, M., Presley, N. A., Menach, A. L., Bradley, C. M., Outten, M., & González, O. (2022) · Malaria Journal · doi:10.1186/s12936-022-04318-z · Cited by 11
Abate, B. B., Sendekie, A. K., Ayele, M., Lake, E. S., Wodaynew, T., Tilahun, B. D., Azmeraw, M., Habtie, T. E., Mezen, M. K., Munie, M. A., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1363284 · Cited by 11
A comprehensive review of cerebral malaria
Beniwal, P., Joshi, J., & Kaur, S. (2024) · Journal of Parasitic Diseases · doi:10.1007/s12639-024-01758-z · Cited by 12
Moraga, P., & Baker, L. (2022) · F1000Research · doi:10.12688/f1000research.122764.1 · Cited by 10
Antibody Dynamics for Plasmodium vivax Malaria: A Mathematical Model
Mehra, S., McCaw, J. M., Flegg, M. B., Taylor, P. G., & Flegg, J. A. (2021) · Bulletin of Mathematical Biology · doi:10.1007/s11538-020-00837-5 · Cited by 11
Taking on Plasmodium vivax malaria: A timely and important challenge
von Seidlein, L., & White, N. J. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003593 · Cited by 11
Satyagraha, A. W., Sadhewa, A., Panggalo, L. V., Subekti, D., Elyazar, I., Soebianto, S., Mahpud, N., Harahap, A. R., & Baird, J. K. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009610 · Cited by 11
Markus, M. B. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s269336 · Cited by 11
Malaria temporal dynamic clustering for surveillance and intervention planning
Legendre, E., Lehot, L., Dieng, S., Rebaudet, S., Thu, A. M., Rae, J. D., Delmas, G., Girond, F., Herbreteau, V., Nosten, F. H., et al. (2023) · Epidemics · doi:10.1016/j.epidem.2023.100682 · Cited by 13
Shukla, M., Hassam, M., Yadav, D. K., Sharma, S., Singh, C., Puri, S., Shrivastava, R., & Verma, V. P. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128305 · Cited by 11
Vivax malaria: a possible stumbling block for malaria elimination in India
Kumar, A., Singh, P. P., Tyagi, S., Raju, H. K., Sahu, S. S., & Rahi, M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1228217 · Cited by 11
Schwabl, P., Camponovo, F., Clementson, C., Early, A. M., Laws, M., Forero-Peña, D. A., Noya, Ó., Grillet, M. E., Vanhove, M., Anthony, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52545-6 · Cited by 10
Chande, A. T., Rishishwar, L., Ban, D., Nagar, S. D., Conley, A. B., Rowell, J. L., Valderrama-Aguirre, A., Medina-Rivas, M. A., & Jordan, I. K. (2020) · Genome Biology and Evolution · doi:10.1093/gbe/evaa154 · Cited by 11
Mittal, P., Mishra, S. K., Kar, S., Pande, V., Sinha, A., & Sharma, A. K. (2020) · Open Biology · doi:10.1098/rsob.200180 · Cited by 10
Goff, M. L., Kendjo, É., Théllier, M., Piarroux, R., Boëlle, P., & Jauréguiberry, S. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac641 · Cited by 10
A New Test of a Theory about Old Mosquitoes
Smith, D. L., Musiime, A. K., Kilama, M., Lindsay, S. W., & Kiware, S. S. (2020) · Trends in Parasitology · doi:10.1016/j.pt.2020.10.011 · Cited by 10
Ruwanpura, V., Nowak, S., Gerth‐Guyette, E., Theodora, M., Lek, D., Haile, M., Grietens, K. P., Price, R. N., Lynch, C. A., & Thriemer, K. (2021) · Asia & the Pacific Policy Studies · doi:10.1002/app5.314 · Cited by 9
Douglas, N. M., Burkot, T. R., & Price, R. N. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab259 · Cited by 12
Sanchez-Castro, E. E., Cahuana, G. M., García-Ríos, C. J., Guerra-Duarte, C., Chauca, P., Tapia‐Limonchi, R., Chenet, S. M., Soria, B., Chávez-Olórtegui, C., & Tejedo, J. R. (2022) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2022.100347 · Cited by 10
Fadilah, I., Commons, R. J., Châu, N. H., Chu, C. S., Day, N., Koh, G. C. K. W., Green, J. A., Lacerda, M., Llanos‐Cuentas, A., Nelwan, E. J., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004411 · Cited by 9
Genomic exploration of the journey of Plasmodium vivax in Latin America
Lefebvre, M. J. M., Degrugillier, F., Arnathau, C., Fontecha, G. A., Noya, Ó., Houzé, S., Severini, C., Pradines, B., Berry, A., Trape, J., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012811 · Cited by 11
MK-7602: a potent multi-stage dual-targeting antimalarial
Favuzza, P., Palandri, J., Ruiz, M. D. L., Bailey, W., Boyce, C. W., Danziger, A., Fawaz, M. V., Kelly, M., Murgolo, N., Robbins, J. A., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.106061 · Cited by 9
Human infections with neglected vector-borne pathogens in China: A systematic review
Sun, Y.-Q., Wang, T., Zhang, Y., Che, T.-L., Meng, F., Teng, A.-Y., Liu, M., Li, T., Jiang, B., Xu, Q., et al. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100427 · Cited by 10
Sutanto, E., Pava, Z., Echeverry, D. F., Lopera-Mesa, T. M., Montenegro, L. M., Yasnot, M. F., Benavente, E. D., Pearson, R. D., Herrera, S., Arévalo‐Herrera, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-46076-1 · Cited by 9
Bansal, G. P., Araújo, M. D. S., Cao, Y., Shaffer, E. S., Araújo, J. E., Medeiros, J. F., Hayashi, C. T. H., Vinetz, J. M., & Kumar, N. (2024) · Infection and Immunity · doi:10.1128/iai.00374-23 · Cited by 9
Malaria: Past, present and future
Salkeld, J., Duncan, A., & Minassian, A. M. (2024) · Clinical Medicine · doi:10.1016/j.clinme.2024.100258 · Cited by 9
Medeiros, C. M. P., Moreira, E. U. M., Pires, C. V., Torres-Martínez, L. M., Guimarães, L. F. F., Alves, J. R. S., Lima, B. A. S., Fontes, C. J. F., Costa, H. L., de Brito, C. F. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232786 · Cited by 9
Cho, J., You, S. C., Lee, S., Park, D., Park, B., Hripcsak, G. M., & Park, R. W. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17217824 · Cited by 9
Rajkhowa, P., Nath, C., Dutta, A., Misurya, I., Sharma, N. K., Barman, B., Longkumer, C., Lynrah, K. G., Sarmah, D., & Ruram, A. A. (2020) · Cureus · doi:10.7759/cureus.11463 · Cited by 9
Yadav, P., Rawat, V., Love, S. K., & Verma, V. P. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117032 · Cited by 10
Overview of national and local efforts to eliminate malaria in Thailand
Saeung, M., Jupatanakul, N., Hii, J., Thanispong, K., Chareonviriyaphap, T., & Manguin, S. (2024) · Trends in Parasitology · doi:10.1016/j.pt.2024.11.006 · Cited by 7
Haile, G. T., Koya, P. R., & Legesse, F. M. (2025) · Frontiers in Applied Mathematics and Statistics · doi:10.3389/fams.2024.1487291 · Cited by 8
Cárdenas, N. C., Sanchez, F., Lopes, F. P. N., & Machado, G. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14627 · Cited by 8
Bertozzi-Villa, A., Bever, C. A., Gerardin, J., Proctor, J. L., Wu, M., Harding, D., Hollingsworth, T. D., Bhatt, S., & Gething, P. W. (2023) · Malaria Journal · doi:10.1186/s12936-023-04535-0 · Cited by 8
Juhairiyah, J., Andiarsa, D., Indriyati, L., Ridha, M. R., Prasodjo, R. S., & Dhewantara, P. W. (2020) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/traa125 · Cited by 9
Sousa, A., Alba, M. A., Vetter, M., García-Barrón, L., & Morales, J. (2021) · Euro-Mediterranean Journal for Environmental Integration · doi:10.1007/s41207-021-00245-8 · Cited by 8
CYP2D6 Genetic Variation and Its Implication for Vivax Malaria Treatment in Madagascar
Mehlotra, R. K., Gaedigk, A., Howes, R. E., Rakotomanga, T. A., Ratsimbasoa, A. C., & Zimmerman, P. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.654054 · Cited by 8
The Drug Resistance of Plasmodium falciparum and P. vivax in Iran: A Review Article
Heidari, A., & Keshavarz, H. (2021) · Iranian Journal of Parasitology · doi:10.18502/ijpa.v16i2.6265 · Cited by 8
Controlled Human Malaria Infection Studies in Africa—Past, Present, and Future
Kibwana, E., Kapulu, M. C., & Bejon, P. (2022) · Current topics in microbiology and immunology · doi:10.1007/82_2022_256 · Cited by 8
Yan, G., Lee, M., Zhou, G., Jiang, A., Degefa, T., Zhong, D., Wang, X., Hemming‐Schroeder, E., Mukabana, W. R., Dent, A. E., et al. (2022) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-1254 · Cited by 8
Liu, M., Liu, Y., Ly, P., Xia, S., Huy, R., Zhou, X., & Liu, J. (2023) · Infectious Disease Modelling · doi:10.1016/j.idm.2023.01.006 · Cited by 8
Karnatak, M., Hassam, M., Vanangamudi, M., Sharma, S., Yadav, D. K., Singh, C., Puri, S., Rawat, V., & Verma, V. P. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128372 · Cited by 8
Obaldía, N., de Mosca, I. B., Lasso, J., Ávila, M., Quijada, M. R., Núñez, M., & Marti, M. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010327 · Cited by 8
Watson, Q. D., Carias, L. L., Malachin, A., Redinger, K. R., Bosch, J., Bardelli, M., Baldor, L., Feufack-Donfack, L. B., Popovici, J., Moon, R. W., et al. (2023) · Malaria Journal · doi:10.1186/s12936-023-04766-1 · Cited by 8
Origin of the human malaria parasite Plasmodium vivax
Sharp, P. M., Plenderleith, L. J., Culleton, R. L., & Hahn, B. H. (2024) · Trends in Parasitology · doi:10.1016/j.pt.2024.05.001 · Cited by 7
Pian, H., Yang, M., Sun, X., & Zheng, Z. J. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.131973 · Cited by 7
Starck, T., Dambach, P., Rouamba, T., Tinto, H., Osier, F. H. A., Oldenburg, C. E., Adam, M., Bärnighausen, T., Jaenisch, T., & Bulstra, C. A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1009865 · Cited by 8
The threat of increased transmission of non-knowlesi zoonotic malaria in humans: a systematic review
Chaturvedi, R., Biswas, S., Bisht, K., & Sharma, A. K. (2023) · Parasitology · doi:10.1017/s003118202300077x · Cited by 8
Recent advances in the synthesis and antimalarial activity of 1,2,4-trioxanes
Rathi, K., Shukla, M., Hassam, M., Shrivastava, R., Rawat, V., & Verma, V. P. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.107043 · Cited by 8
Nosten, F. H., & Phyo, A. P. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31273-5 · Cited by 7
Nourani, L., Mehrizi, A. A., Zakeri, S., & Djadid, N. D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266067 · Cited by 7
Metadata
- Authors
- Battle, K. E., Lucas, T. C. D., Nguyen, M., Howes, R. E., Nandi, A. K., Twohig, K. A., Pfeffer, D. A., Cameron, E., Rao, P. C., Casey, D., Gibson, H. S., Rozier, J. A., Dalrymple, U., Keddie, S. H., Collins, E. L., Harris, J. R., Guerra, C. A., Thorn, M. P., Bisanzio, D., Fullman, N., Huynh, C. K., Kulikoff, X., Kutz, M. J., Lopez, A. D., Mokdad, A. H., Naghavi, M., Nguyen, G., Shackelford, K. A., Vos, T., Wang, H., Lim, S. S., Murray, C. J. L., Price, R. N., Baird, J. K., Smith, D. L., Bhatt, S., Weiss, D. J., Hay, S. I., & Gething, P. W.
- Affiliations
- University of Oxford (GB)
- Charles Darwin University (AU)
- University of Washington (US)
- Public Health – Seattle & King County (US)
- Public Health England (GB)
- Medical Care Development International (US)
- University of Nottingham (GB)
- Imperial College London (GB)
- Corresponding author
- Gething, Peter W
- ORCID
- Battle, Katherine E
- Lucas, Tim C D
- Howes, Rosalind E
- Nandi, Anita K
- Twohig, Katherine A
- Pfeffer, Daniel A
- Cameron, Ewan
- Gibson, Harry S
- Rozier, Jennifer A
- Dalrymple, Ursula
- Keddie, Suzanne H
- Guerra, Carlos A
- Bisanzio, Donal
- Fullman, Nancy
- Kulikoff, Xie
- Mokdad, Ali H
- Naghavi, Mohsen
- Vos, Theo
- Wang, Haidong
- Lim, Stephen S
- Murray, Christopher J L
- Price, Ric N
- Baird, J Kevin
- Smith, David L
- Bhatt, Samir
- Weiss, Daniel J
- Hay, Simon I
- Gething, Peter W
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 394
- Issue
- 10195
- Pages
- 332-343
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC6675736
- OpenAlex
- W2950607694
- Cited by
- 409
- References
- 36
- Citations by year
- 2026: 31 · 2025: 41 · 2024: 63 · 2023: 69 · 2022: 59 · 2021: 83 · 2020: 49 · 2019: 14
- FWCI
- 47.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Bill and Melinda Gates Foundation
- Wellcome Trust (200909/Z/16/Z, 200909)
- Medical Research Council (MR/R015600/1)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Keywords
- Plasmodium vivax, vivax malaria, malaria endemicity, clinical burden, Plasmodium falciparum, malaria elimination, global burden of disease, sub-Saharan Africa, Americas, Southeast Asia, western Pacific, socio-economic instability
- MeSH terms
- Africa, Americas, Asia, Southeastern, Bayes Theorem, Humans, Population Surveillance, Global Health, Malaria, Vivax, Endemic Diseases, Oceania, Spatio-Temporal Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
